| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 03/29/2011 | US7914791 Vaccine |
| 03/29/2011 | US7914787 Provide inter alia a bi-specific antibody or antibody fragment having one arm that specifically binds a targeted tissue and one other arm that specifically binds a targetable conjugate that can be modified for use in a wide variety of diagnostic and therapeutic applications |
| 03/29/2011 | US7914780 Aminopeptidase A (APA) targeting peptides for the treatment of cancer |
| 03/29/2011 | US7914768 Stabiliser for radiopharmaceuticals |
| 03/29/2011 | US7914767 Oral DTPA for radionuclide chelation |
| 03/29/2011 | US7914766 Inorganic resins for clinical use of 213Bi generators |
| 03/29/2011 | CA2407514C Rgd (arg-gly-asp) coupled to (neuro)peptides |
| 03/29/2011 | CA2400856C Imaging agents for diagnosis of parkinson's disease |
| 03/29/2011 | CA2345276C Flt4 (vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 03/29/2011 | CA2165573C Anti-.alpha.v-integrin monoclonal antibody |
| 03/24/2011 | WO2011035140A1 Methods and compositions for delivery of contrast moieties to the lungs |
| 03/24/2011 | WO2011035024A2 Unsealed, non-colloidal radiopharmaceutical compositions and methods for treatment of abnormal tissue |
| 03/24/2011 | WO2011033118A1 Preparation and use of 68ga-comprising particles for lung ventilation/perfusion and pet imaging and quantification |
| 03/24/2011 | WO2011033112A2 68ga-labeled human serum albumin |
| 03/24/2011 | WO2011033033A1 Labelled biotin conjugates |
| 03/24/2011 | WO2011032973A1 Selective detection of bone metastases in renal clear cell carcinoma |
| 03/24/2011 | WO2011009539A8 ε-POLYLYSINE CONJUGATES AND USE THEREOF |
| 03/24/2011 | US20110071189 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 03/24/2011 | US20110071188 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 03/24/2011 | US20110071187 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 03/24/2011 | US20110070161 Active enantiomer |
| 03/24/2011 | US20110070160 Dose Synthesis Mosule for Biomaker Generator System |
| 03/24/2011 | US20110070159 Compositions comprising red microalgae polysaccharides and metals |
| 03/24/2011 | US20110070158 Quality Control Module for Biomarker Generator System |
| 03/24/2011 | US20110070157 Radiometal-labeled amino acid analogs, imaging and therapeutic agents incorporating the same, and methods using the same |
| 03/24/2011 | US20110070156 Combining Radioimmunotherapy and Antibody-Drug Conjugates for Improved Cancer Therapy |
| 03/24/2011 | US20110070155 Anti-CD74 Immunoconjugates and Methods |
| 03/24/2011 | US20110070154 Artificial cells |
| 03/24/2011 | US20110070153 Artificial cells |
| 03/24/2011 | CA2771316A1 Selective detection of bone metastases in renal clear cell carcinoma |
| 03/23/2011 | EP2299265A1 Cancer eradication program |
| 03/23/2011 | EP1501553B1 Cell growth, induction and lysis in an antibody-coated microplate for use in an elisa |
| 03/23/2011 | CN101990442A Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties |
| 03/23/2011 | CN101987226A Radioactive particle chain connected by controlled degradable magnesium and magnesium alloy pipe |
| 03/23/2011 | CN101648027B Positron emission tomography (PET) diagnostic radioactive drug and preparation method thereof |
| 03/23/2011 | CN101537193B Vesicle monoamine transporter target bound drug and preparation method thereof |
| 03/22/2011 | US7910694 Homing peptides to receptors of heart vasculature |
| 03/22/2011 | US7910693 Prostate cancer diagnosis and treatment |
| 03/22/2011 | US7910594 Antiproliferative agents; gene overexpression |
| 03/22/2011 | US7910541 Enzyme treatment of foodstuffs for celiac sprue |
| 03/22/2011 | US7910323 Methods for identifying the effect of a drug agent on the metabolism of sugars and fats in an individual |
| 03/22/2011 | US7910103 Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
| 03/22/2011 | US7910093 administering to mammals a Sindbis virus comprising gene that code detectable labels, concurrently with anticarcinogenic agents, and analyzing the amount of cancer cells in the body of the mammal |
| 03/22/2011 | US7910089 Sialogogue, oral composition and food product containing the same |
| 03/22/2011 | US7910086 Nanoparticles for protein drug delivery |
| 03/22/2011 | US7910059 For the determination of an analyte or analytes such as proteins, peptides, nucleic acids, carbohydrates, lipids, steroids and small molecules by mass analysis |
| 03/22/2011 | CA2454228C Radiolabeled neuropeptide y y5 receptor antagonists |
| 03/22/2011 | CA2407592C Small technetium-99m and rhenium labeled agents and methods for imaging tumors |
| 03/17/2011 | WO2011031919A2 Non-radioactive phospholipid compounds, compositions, and methods of use |
| 03/17/2011 | WO2011031667A1 Methods for diagnosis and intervention of hepatic disorders |
| 03/17/2011 | WO2011030160A1 Detection of mycobacteria |
| 03/17/2011 | WO2010028776A8 Piperazine derivatives for binding and imaging amyloid plaques and their use |
| 03/17/2011 | US20110064662 Kit for producing molecular probe for pet screening for drug discovery |
| 03/17/2011 | US20110064661 Non-radioactive phospholipid compounds, compositions, and methods of use |
| 03/17/2011 | US20110064660 Deuterated alkyl phospholipid compounds, compositions, and methods of use |
| 03/17/2011 | US20110064659 Glutamine biomarkers for depression |
| 03/17/2011 | US20110064658 RGD-(bacterio)chlorophyll conjugates for photodynamic therapy and Imaging of Necrotic tumors |
| 03/17/2011 | US20110064657 Labeled inhibitors of prostate specific membrane antigen (psma), biological evaluation, and use as imaging agents |
| 03/17/2011 | US20110064656 Methods of Determining Renal Function using Technetium-99m Tricarbonyl-nitrilotriacetic acid |
| 03/17/2011 | US20110064655 Biomarkers for depression |
| 03/17/2011 | US20110064654 Prostate cancer diagnosis and treatment |
| 03/17/2011 | US20110064653 Class I Anti-CEA Antibodies and Uses Thereof |
| 03/17/2011 | US20110064652 Nanoparticles for targeted delivery of active agents to the lung |
| 03/17/2011 | US20110064651 Recombinant nucleotide sequence, cell or vector containing the same and method for using cell containing the same to encode anti-polyethylene glycol monoclonal antibodies |
| 03/17/2011 | US20110064650 Microorganisms for preventing and treating neoplasms accompanying cellular therapy |
| 03/17/2011 | CA2773824A1 Methods for diagnosis and intervention of hepatic disorders |
| 03/16/2011 | EP2295475A1 Polymer precursors of radiolabeled compounds, and methods of making and using the same |
| 03/16/2011 | EP2295435A1 Substituted porphyrins and their therapeutic use |
| 03/16/2011 | EP1412388B1 Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin |
| 03/16/2011 | CN101985483A Iodinated PRTH, and preparation method and application thereof |
| 03/16/2011 | CN101985456A Bone-seeking 99mTc-IPrDP coordination compound as well as preparation method and application thereof |
| 03/16/2011 | CN101985443A Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 03/16/2011 | CN101985045A Application of <131>I marked SAP for preparing medicine for diagnosing amyloidosis |
| 03/15/2011 | US7906630 Method for identifying peptides in a biological sample |
| 03/15/2011 | US7906618 Peptide capable of binding to insulin-binding protein and adsorbent |
| 03/15/2011 | US7906478 Personal-care articles having self-assembling peptides |
| 03/15/2011 | US7906477 Proteases of human kallikrein 2 (hK2); tissue imaging |
| 03/15/2011 | US7906121 Methods and compositions for generating bioactive assemblies of increased complexity and uses |
| 03/15/2011 | US7906103 Methods and compositions for targeted drug delivery |
| 03/15/2011 | US7906102 Ligands to radiation-induced molecules |
| 03/10/2011 | WO2011028935A2 Methods of treating mitochondrial disorders using metalloporhyrins |
| 03/10/2011 | WO2011028811A2 Dual variable domain immunoglobulins and uses thereof |
| 03/10/2011 | WO2011027584A1 Molecular probe for imaging of pancreatic islet, and use thereof |
| 03/10/2011 | WO2010126279A3 Cytokeratin 17-specific human antibody |
| 03/10/2011 | US20110060605 Methods for predicting responsiveness of a disease or disorder to a receptor tyrosine kinase inhibitor by analysis of mutations in pik3ca |
| 03/10/2011 | US20110060232 Retinal flow cytometry |
| 03/10/2011 | US20110059014 Compounds and methods of making compounds |
| 03/10/2011 | US20110059013 Anti-robo4 antibodies and uses therefor |
| 03/10/2011 | US20110059012 Identification of cd8+ t cells that are cd161hi and/or il18r (alpha) hi and have rapid drug efflux capacity |
| 03/10/2011 | US20110059011 Diagnosis and treatment of diseased and damaged tissue |
| 03/10/2011 | US20110059010 Dual phase drug release system |
| 03/10/2011 | CA2772628A1 Dual variable domain immunoglobulins and uses thereof |
| 03/10/2011 | CA2772218A1 Methods of treating mitochondrial disorders using metalloporphyrins |
| 03/10/2011 | CA2771254A1 Novel diagnostic agents for the non-invasive in vivo imaging of aminopeptidase n (apn/cd13) |
| 03/09/2011 | EP2292666A2 Neoplasm specific antibodies and uses thereof |
| 03/09/2011 | EP2291678A2 Improved methods and compositions for f-18 labeling of proteins, peptides and other molecules |
| 03/09/2011 | EP2291406A1 An anti-cancer cytotoxic monoclonal antibody |
| 03/09/2011 | EP1732602B1 Detecting the mcsp-surface expression of a cell |
| 03/08/2011 | US7902144 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same |
| 03/08/2011 | US7901667 Bridgehead labelled compounds and methods of using the same |